The molecular and genetic basis of enhanced TLR7 responses to SARS-CoV-2 in patients with chilblains has yet to be elucidated, although TLR7 hyperactivation is known to induce other autoimmune disorders including lupus, of which chilblains are a common cutaneous manifestation (127). This evidence concerns the gene TLR7 and systemic lupus erythematosus.